| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |